{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T19:29:56Z","timestamp":1791487796613,"version":"4.3.4"},"reference-count":38,"publisher":"Informa UK Limited","issue":"5","license":[{"start":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T00:00:00Z","timestamp":1778803200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T00:00:00Z","timestamp":1778803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"funder":[{"name":"GlaxoSmithKline","award":["219426"],"award-info":[{"award-number":["219426"]}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Pharmacoeconomics & Outcomes Research"],"published-print":{"date-parts":[[2026,5,28]]},"DOI":"10.1080\/14737167.2026.2671770","type":"journal-article","created":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T09:19:17Z","timestamp":1778663957000},"page":"683-691","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":1,"title":["Estimating respiratory syncytial virus health utility values for older adults and their caregivers in the Japanese population: a time trade-off study"],"prefix":"10.1080","volume":"26","author":[{"given":"Regina","family":"Rendas-Baum","sequence":"first","affiliation":[{"name":"IQVIA QualityMetric","place":["Providence, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakob","family":"Bjorner","sequence":"additional","affiliation":[{"name":"IQVIA QualityMetric","place":["Providence, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Preckler","sequence":"additional","affiliation":[{"name":"GSK","place":["Wavre, Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taizo","family":"Matsuki","sequence":"additional","affiliation":[{"name":"GSK","place":["Tokyo, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufan","family":"Ho","sequence":"additional","affiliation":[{"name":"GSK","place":["Singapore, Singapore"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Molnar","sequence":"additional","affiliation":[{"name":"GSK","place":["Wavre, Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Noto","sequence":"additional","affiliation":[{"name":"Niigata University of Health and Welfare","place":["Niigata, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ataru","family":"Igarashi","sequence":"additional","affiliation":[{"name":"The University of Tokyo","place":["Tokyo, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,5,15]]},"reference":[{"key":"e_1_3_8_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/irv.12928"},{"key":"e_1_3_8_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-023-00777-2"},{"key":"e_1_3_8_4_1","unstructured":"CDC. RSV ACIP vaccine recommendations. 2023 [cited 2024 Nov 17]. Available from: https:\/\/www.cdc.gov\/acip-recs\/hcp\/vaccine-specific\/rsv.html?CDC_AAref_Val=https:\/\/www.cdc.gov\/vaccines\/hcp\/acip-recs\/vacc-specific\/rsv.html"},{"key":"e_1_3_8_5_1","unstructured":"CDC. Learn about RSV in older adults with chronic medical conditions. Centers for Disease Control and Prevention. 2023 [cited 2024 Nov 17]. Available from: https:\/\/www.cdc.gov\/rsv\/adults\/?CDC_AAref_Val=https:\/\/www.cdc.gov\/rsv\/high-risk\/older-adults.html"},{"key":"e_1_3_8_6_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit471"},{"key":"e_1_3_8_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/irv.12754"},{"key":"e_1_3_8_8_1","unstructured":"UK Department of Health & Social Care. Respiratory syncytial virus (RSV) immunization program for infants and older adults: JCVI full statement 11 September 2023 - gov.Uk. [cited 2024 Jan 11]. Available from: https:\/\/www.gov.uk\/government\/publications\/rsv-immunisation-programme-jcvi-advice-7-june-2023\/respiratory-syncytial-virus-rsv-immunisation-programme-for-infants-and-older-adults-jcvi-full-statement-11-september-2023"},{"key":"e_1_3_8_9_1","unstructured":"Respiratory syncytial virus (RSV): for health professionals. 2022 [cited 2024 Nov 17]. Available from: https:\/\/www.canada.ca\/en\/public-health\/services\/diseases\/respiratory-syncytial-virus-rsv\/health-professionals.html"},{"key":"e_1_3_8_10_1","unstructured":"GSK. Japan\u2019s ministry of health labor and welfare approve GSK\u2019s arexvy the country\u2019s first respiratory syncytial virus (RSV) vaccine for older adults | GSK. [cited 2024 Nov 17]. Available from: https:\/\/www.gsk.com\/en-gb\/media\/press-releases\/japan-s-ministry-of-health-labour-and-welfare-approves-gsk-s-arexvy\/"},{"key":"e_1_3_8_11_1","unstructured":"ABRYSVO intramuscular injection (Drug Information Sheet). n.d. [cited 2026 Feb 8]. Available from: https:\/\/www.rad-ar.or.jp\/siori\/english\/search\/result?n=46996"},{"key":"e_1_3_8_12_1","unstructured":"Japan\u2019s Ministry of Health. Labour and welfare accepts regulatory application to expand use of GSK\u2019s RSV vaccine arexvy in adults aged 18\u201349 at increased risk of severe RSV disease | GSK. n.d. [cited 2026 Feb 8]. Available from: https:\/\/www.gsk.com\/en-gb\/media\/press-releases\/japan-s-ministry-of-health-labour-and-welfare-accepts-regulatory-application-to-expand-use-of-gsk-s-rsv-vaccine-arexvy\/"},{"key":"e_1_3_8_13_1","doi-asserted-by":"publisher","DOI":"10.2217\/fvl-2023-0069"},{"key":"e_1_3_8_14_1","doi-asserted-by":"publisher","DOI":"10.2147\/CEOR.S382495"},{"key":"e_1_3_8_15_1","doi-asserted-by":"publisher","DOI":"10.1080\/13696998.2023.2213125"},{"key":"e_1_3_8_16_1","doi-asserted-by":"publisher","DOI":"10.15585\/MMWR.MM7240A2"},{"key":"e_1_3_8_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/irv.13031"},{"key":"e_1_3_8_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-020-00991-7"},{"key":"e_1_3_8_19_1","unstructured":"Core 2 Health. Strategic Integrated Scientific Research Project. Guideline for preparing cost-effectiveness evaluation to the central social insurance medical council. 2024 [cited 2024 Nov 17]. Available from: https:\/\/c2h.niph.go.jp\/tools\/guideline\/guideline_en_2024.pdf"},{"key":"e_1_3_8_20_1","unstructured":"Baum R Molnar D. A time trade-off (TTO) study to estimate respiratory syncytial virus (RSV) related utility values for older adults in the United States (US). ISPOR; [cited 2024 Nov 17]. Available from: https:\/\/www.ispor.org\/docs\/default-source\/intl2023\/ispor23rendas-baumposter126708-pdf.pdf?sfvrsn=2519d505_0"},{"key":"e_1_3_8_21_1","unstructured":"Public health research center. Ethics review committee on research on people. [cited 2024 Jan 11]. Available from: https:\/\/www.phrf.jp\/rinri\/"},{"key":"e_1_3_8_22_1","unstructured":"Statistics Bureau Home Page\/JAPAN STATISTICAL YEARBOOK. Chapter 2 population and households. 2022 [cited 2024 Jan 11]. Available from: https:\/\/www.stat.go.jp\/english\/data\/nenkan\/71nenkan\/1431-02.html"},{"key":"e_1_3_8_23_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-018-0672-z"},{"key":"e_1_3_8_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4733.2010.00773.x"},{"key":"e_1_3_8_25_1","doi-asserted-by":"publisher","DOI":"10.1201\/9780203753736"},{"key":"e_1_3_8_26_1","doi-asserted-by":"publisher","DOI":"10.2165\/00019053-200826030-00006"},{"key":"e_1_3_8_27_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-023-02792-z"},{"key":"e_1_3_8_28_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11101605"},{"key":"e_1_3_8_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.04.072"},{"key":"e_1_3_8_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2013.10.023"},{"key":"e_1_3_8_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2013.07.024"},{"key":"e_1_3_8_32_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0163567"},{"key":"e_1_3_8_33_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-017-3046-1"},{"key":"e_1_3_8_34_1","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2024.2410898"},{"key":"e_1_3_8_35_1","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2024.2323128"},{"key":"e_1_3_8_36_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiac069"},{"key":"e_1_3_8_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.resinv.2024.06.003"},{"key":"e_1_3_8_38_1","unstructured":"Roy LMC. Deriving health utility weights for infants with respiratory syncytial virus (RSV). 2013. Available from: https:\/\/open.library.ubc.ca\/soa\/cIRcle\/collections\/ubctheses\/24\/items\/1.0074259"},{"key":"e_1_3_8_39_1","doi-asserted-by":"publisher","DOI":"10.1093\/med\/9780198725923.001.0001"}],"container-title":["Expert Review of Pharmacoeconomics & Outcomes Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14737167.2026.2671770","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/14737167.2026.2671770","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14737167.2026.2671770","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T08:17:41Z","timestamp":1782461861000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14737167.2026.2671770"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,15]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5,28]]}},"alternative-id":["10.1080\/14737167.2026.2671770"],"URL":"https:\/\/doi.org\/10.1080\/14737167.2026.2671770","relation":{},"ISSN":["1473-7167","1744-8379"],"issn-type":[{"value":"1473-7167","type":"print"},{"value":"1744-8379","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,15]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierp20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierp20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-11-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-31","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-15","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}